The Independent Market Observer

Covid-19 Checkup

Posted by Brad McMillan, CFA, CAIA, MAI

Find me on:

This entry was posted on Mar 30, 2022 4:01:59 PM

and tagged Commentary

Leave a comment

Covid-19For the past couple of weeks, we’ve been talking about two things: the war in Ukraine (and its effects) and inflation and the Fed. These have very much been the hot topics, and deservedly so. But with a lull in the news on both, it’s time to check back in on Covid, which has not gone away.

Signs of Resurgence?

Covid is, it’s true, much less of a problem than it has been, which is why it is out of the headlines. Reported daily infections have dropped down to under 30,000 per day, on a seven-day average basis, which is the lowest we have seen since last summer. Deaths and hospitalizations are down as well, and the positive testing rate has stayed well below the 5 percent threshold that signals the pandemic is under control. From a social point of view as well, this level of Covid seems to be something that we as a society are prepared to live with.

But there are signs we need to be prepared for another resurgence. A new variant of the virus now accounts for the majority of cases in several states. Traces of the Covid virus are trending up in wastewater samples. Although the number of cases is low, over the past couple of weeks, it has stopped dropping. With large numbers of people still unvaccinated and with most areas no longer masking, another wave is quite possible.

Even if we get one, though, here in the U.S. the economic impact is likely to be small. After the Omicron wave, the next one—if any—will likely be much milder. We don’t need to worry as much about the U.S. It is the next Covid wave in China that should concern us.

China Remains Vulnerable

China, which has consistently pursued a zero-Covid policy driven by mass shutdowns, remains vulnerable in ways the U.S. is not. Here in the U.S., we have effective vaccines; in China, they don’t. Here in the U.S., most people have been exposed to the virus in one way or another; in China, they have not. Here in the U.S., we have been through the Omicron wave. In China, they have not.

That means that most people in China have little or no immunity. If the virus does get loose, the damage will look like what we have seen over the past two years. In other words, all of the pain and disruption we have suffered over the past two years, and have largely moved past, is very likely still in front of the Chinese if Covid gets loose.

Production Disruption

To our point today, if the virus does get loose there, which is more likely as more contagious strains evolve, all of the economic disruption is also in front of them—and in front of the supply chains that continue to supply the U.S. with many goods. This is the next economic stage of the pandemic: the disruption of production.

It may not happen. China has been remarkably successful in containing the virus so far, and the actual disruption to Chinese manufacturing has been minimal. Most of the supply chain problems we have observed come from transportation problems, not a shortage of actual supply. As long as that continues, we can reasonably expect the supply chain problems to continue to ease. But as more contagious strains continue to evolve, the ability to keep infections contained gets harder and harder, and the odds of a breakout increase.

What to Watch

This will be the next stage of the pandemic. From a social and medical perspective, we have largely moved past it here in the U.S. From an economic standpoint, we are getting close—here in the U.S. But the next phase of the pandemic is likely to be more about economics as it disrupts production in China, and that is what we need to watch now.


Subscribe via Email

Crash-Test Investing
New call-to-action

Hot Topics



New Call-to-action

Conversations

Archives

see all

Subscribe


Disclosure

The information on this website is intended for informational/educational purposes only and should not be construed as investment advice, a solicitation, or a recommendation to buy or sell any security or investment product. Please contact your financial professional for more information specific to your situation.

Certain sections of this commentary contain forward-looking statements that are based on our reasonable expectations, estimates, projections, and assumptions. Forward-looking statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Past performance is not indicative of future results. Diversification does not assure a profit or protect against loss in declining markets.

The S&P 500 Index is a broad-based measurement of changes in stock market conditions based on the average performance of 500 widely held common stocks. All indices are unmanaged and investors cannot invest directly in an index.

The MSCI EAFE (Europe, Australia, Far East) Index is a free float‐adjusted market capitalization index that is designed to measure the equity market performance of developed markets, excluding the U.S. and Canada. The MSCI EAFE Index consists of 21 developed market country indices.

One basis point (bp) is equal to 1/100th of 1 percent, or 0.01 percent.

Third-party links are provided to you as a courtesy. We make no representation as to the completeness or accuracy of information provided on these websites. Information on such sites, including third-party links contained within, should not be construed as an endorsement or adoption by Commonwealth of any kind. You should consult with a financial advisor regarding your specific situation.

Member FINRASIPC

Please review our Terms of Use

Commonwealth Financial Network®